| | |
每股
|
| |
总计
|
| ||||||
公开发行价
|
| | | $ | 25.000 | | | | | $ | 250,000,000 | | |
承保折扣(1)
|
| | | $ | 0.875 | | | | | $ | 8,750,000 | | |
向出售股东扣除费用前的收益
|
| | | $ | 24.125 | | | | | $ | 241,250,000 | | |
| 杰弗瑞 | | |
摩根士丹利
|
| |
美国银行证券
|
|
|
瑞士信贷(Credit Suisse)
|
| |
巴克莱
|
|
| 目录 | | | |||||
| | | | | | 第 页 | | |
|
招股说明书摘要
|
| | | | 1 | | |
|
风险因素
|
| | | | 19 | | |
|
有关前瞻性陈述的特别说明
|
| | | | 25 | | |
|
收益使用情况
|
| | | | 27 | | |
|
股利政策
|
| | | | 28 | | |
|
大写
|
| | | | 29 | | |
|
管理
|
| | | | 30 | | |
|
某些关系和关联方交易
|
| | | | 36 | | |
|
委托人和销售股东
|
| | | | 38 | | |
|
股本说明
|
| | | | 41 | | |
|
有资格未来出售的股票
|
| | | | 49 | | |
|
美国联邦所得税和遗产税对非美国持有者的某些后果
|
| | | | 51 | | |
|
承销
|
| | | | 54 | | |
|
法律事务
|
| | | | 61 | | |
|
专家
|
| | | | 61 | | |
| | |
截至12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(以千为单位,不包括每股和每股数据)
|
| |||||||||||||||
营业报表和综合收益(亏损)数据: | | ||||||||||||||||||
收入
|
| | | $ | 243,530 | | | | | $ | 208,511 | | | | | $ | 163,719 | | |
收入成本
|
| | | | 100,765 | | | | | | 79,770 | | | | | | 71,043 | | |
运营费用: | | | | | | | | | | | | | | | | | | | |
销售和营销
|
| | | | 19,202 | | | | | | 10,732 | | | | | | 9,416 | | |
研发
|
| | | | 19,644 | | | | | | 11,633 | | | | | | 10,478 | | |
一般和行政
|
| | | | 88,482 | | | | | | 47,926 | | | | | | 43,393 | | |
无形资产摊销
|
| | | | 37,414 | | | | | | 36,241 | | | | | | 31,625 | | |
折旧摊销费用
|
| | | | 2,443 | | | | | | 2,596 | | | | | | 2,416 | | |
总运营费用
|
| | | | 167,185 | | | | | | 109,128 | | | | | | 97,328 | | |
运营收入(亏损)
|
| | | | (24,420) | | | | | | 19,613 | | | | | | (4,652) | | |
其他费用: | | | | | | | | | | | | | | | | | | | |
利息支出
|
| | | | (25,296) | | | | | | (28,004) | | | | | | (27,802) | | |
其他,净额
|
| | | | (465) | | | | | | (760) | | | | | | (107) | | |
其他费用合计
|
| | | | (25,761) | | | | | | (28,764) | | | | | | (27,909) | | |
所得税前收入(亏损)
|
| | | | (50,181) | | | | | | (9,151) | | | | | | (32,561) | | |
所得税拨备(受益)
|
| | | | (784) | | | | | | (225) | | | | | | 697 | | |
净收益(亏损)
|
| | | | (49,397) | | | | | | (8,926) | | | | | | (33,258) | | |
其他综合(亏损): | | | | | | | | | | | | | | | | | | | |
外币折算调整,税后净额
|
| | | | 5,045 | | | | | | 433 | | | | | | (16,721) | | |
利率互换的公允价值变动,税后净额
|
| | | | (1,135) | | | | | | (4,283) | | | | | | 1,079 | | |
其他综合收益(亏损)合计
|
| | | | 3,910 | | | | | | (3,850) | | | | | | (15,642) | | |
综合收益(亏损)
|
| | | $ | (45,487) | | | | | $ | (12,776) | | | | | $ | (48,900) | | |
|
| | |
截至12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
每股数据: | | | | | | | | | | | | | | | | | | | |
普通股股东每股净收益(亏损):
|
| | | | | | | | | | | | | | | | | | |
基础版
|
| | | $ | (0.37) | | | | | $ | (0.07) | | | | | $ | (0.25) | | |
稀释
|
| | | | (0.37) | | | | | | (0.07) | | | | | | (0.25) | | |
加权平均已发行普通股: | | | | | | | | | | | | | | | | | | | |
基础版
|
| | | | 133,247,212 | | | | | | 132,407,786 | | | | | | 132,407,786 | | |
稀释
|
| | | | 133,247,212 | | | | | | 132,407,786 | | | | | | 132,407,786 | | |
| | |
截至12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(单位:千)
|
| |||||||||||||||
现金流数据: | | | | | | | | | | | | | | | | | | | |
净现金提供人(使用于):
|
| | | | | | | | | | | | | | | | | | |
经营活动
|
| | | $ | 44,810 | | | | | $ | 38,025 | | | | | $ | 11,592 | | |
投资活动
|
| | | | (8,612) | | | | | | (9,517) | | | | | | (73,905) | | |
融资活动
|
| | | | 208,214 | | | | | | (8,489) | | | | | | 57,296 | | |
付息现金
|
| | | | 27,607 | | | | | | 26,428 | | | | | | 25,713 | | |
缴税现金
|
| | | | 12,278 | | | | | | 4,109 | | | | | | 3,165 | | |
非GAAP指标: | | | | | | | | | | | | | | | | | | | |
调整后EBITDA(1)
|
| | | $ | 87,877 | | | | | $ | 68,411 | | | | | $ | 44,964 | | |
调整后净收益(亏损)(1)
|
| | | $ | 22,037 | | | | | $ | 839 | | | | | $ | (17,586) | | |
调整后稀释每股收益(1)
|
| | | $ | 0.17 | | | | | $ | 0.01 | | | | | $ | (0.14) | | |
| | |
截至
2020年12月31日 |
| |||
| | |
(单位:千)
|
| |||
资产负债表数据: | | | | | | | |
现金和现金等价物
|
| | | $ | 271,382 | | |
总资产
|
| | | | 1,269,400 | | |
总负债
|
| | | | 447,268 | | |
股东权益总额
|
| | | | 822,132 | | |
| | |
截至12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(单位:千)
|
| |||||||||||||||
调整后的EBITDA: | | | | | | | | | | | | | | | | | | | |
净亏损(A)
|
| | | $ | (49,397) | | | | | $ | (8,926) | | | | | $ | (33,258) | | |
利息费用(A)
|
| | | | 25,296 | | | | | | 28,004 | | | | | | 27,802 | | |
利息收入(A)
|
| | | | (44) | | | | | | (9) | | | | | | (9) | | |
所得税拨备(A)
|
| | | | (784) | | | | | | (225) | | | | | | 697 | | |
折旧和摊销费用(A)
|
| | | | 2,443 | | | | | | 2,596 | | | | | | 2,416 | | |
无形资产摊销(A)
|
| | | | 40,310 | | | | | | 38,964 | | | | | | 34,595 | | |
货币损失(A)
|
| | | | 715 | | | | | | 431 | | | | | | 23 | | |
股权薪酬费用(B)
|
| | | | 64,507 | | | | | | 1,691 | | | | | | 1,711 | | |
收购相关费用(C)
|
| | | | 1,456 | | | | | | 2,471 | | | | | | 6,718 | | |
集成费用(D)
|
| | | | 78 | | | | | | 546 | | | | | | 2,822 | | |
交易相关费用(E)
|
| | | | 1,908 | | | | | | — | | | | | | — | | |
服务费(F)
|
| | | | 557 | | | | | | 2,057 | | | | | | 1,356 | | |
重组费用(G)
|
| | | | 525 | | | | | | 222 | | | | | | — | | |
固定资产处置损失(H)
|
| | | | 19 | | | | | | 113 | | | | | | 91 | | |
高管招聘费用(I)
|
| | | | 288 | | | | | | 476 | | | | | | — | | |
调整后的EBITDA
|
| | | $ | 87,877 | | | | | $ | 68,411 | | | | | $ | 44,964 | | |
|
| | |
截至12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
调整后净收益(亏损): | | | | | | | | | | | | | | | | | | | |
净亏损(A)
|
| | | $ | (49,397) | | | | | $ | (8,926) | | | | | $ | (33,258) | | |
货币损失(A)
|
| | | | 715 | | | | | | 431 | | | | | | 23 | | |
股权薪酬费用(B)
|
| | | | 64,507 | | | | | | 1,691 | | | | | | 1,711 | | |
收购相关费用(C)
|
| | | | 1,456 | | | | | | 2,471 | | | | | | 6,718 | | |
集成费用(D)
|
| | | | 78 | | | | | | 546 | | | | | | 2,822 | | |
交易相关费用(E)
|
| | | | 1,908 | | | | | | — | | | | | | — | | |
服务费(F)
|
| | | | 557 | | | | | | 2,057 | | | | | | 1,356 | | |
重组费用(G)
|
| | | | 525 | | | | | | 222 | | | | | | — | | |
固定资产处置损失(H)
|
| | | | 19 | | | | | | 113 | | | | | | 91 | | |
高管招聘费用(I)
|
| | | | 288 | | | | | | 476 | | | | | | — | | |
调整对所得税费用的影响(J)
|
| | | | 1,381 | | | | | | 1,758 | | | | | | 2,951 | | |
调整后净收益(亏损)
|
| | | $ | 22,037 | | | | | $ | 839 | | | | | $ | (17,586) | | |
|
| | |
截至12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
调整后稀释后每股收益: | | | | | | | | | | | | | | | | | | | |
稀释后每股收益(A)
|
| | | $ | (0.37) | | | | | $ | (0.07) | | | | | $ | (0.25) | | |
货币损失(A)
|
| | | | 0.01 | | | | | | — | | | | | | — | | |
股权薪酬费用(B)
|
| | | | 0.48 | | | | | | 0.01 | | | | | | 0.01 | | |
收购相关费用(C)
|
| | | | 0.01 | | | | | | 0.02 | | | | | | 0.05 | | |
集成费用(D)
|
| | | | — | | | | | | 0.01 | | | | | | 0.02 | | |
交易相关费用(E)
|
| | | | 0.01 | | | | | | — | | | | | | — | | |
服务费(F)
|
| | | | 0.01 | | | | | | 0.02 | | | | | | 0.01 | | |
重组费用(G)
|
| | | | 0.01 | | | | | | — | | | | | | — | | |
固定资产处置损失(H)
|
| | | | — | | | | | | — | | | | | | — | | |
| | |
截至12月31日的年度
|
| |||||||||||||||
| | |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
高管招聘费用(I)
|
| | | | — | | | | | | 0.01 | | | | | | — | | |
调整对所得税费用的影响(J)
|
| | | | 0.01 | | | | | | 0.01 | | | | | | 0.02 | | |
使用调整后稀释股份的效果(K)
|
| | | | — | | | | | | — | | | | | | — | | |
调整后稀释后每股收益
|
| | | $ | 0.17 | | | | | $ | 0.01 | | | | | $ | (0.14) | | |
稀释加权平均已发行普通股
|
| | | | 133,247,212 | | | | | | 132,407,786 | | | | | | 132,407,786 | | |
潜在稀释流通股的影响(L)
|
| | | | 229,383 | | | | | | — | | | | | | — | | |
调整后稀释后加权平均已发行普通股
|
| | | | 133,476,595 | | | | | | 132,407,786 | | | | | | 132,407,786 | | |
|
| | |
截至
2020年12月31日 |
| |||
| | |
(单位:千)
|
| |||
现金和现金等价物
|
| | | $ | 271,382 | | |
长期债务,包括当前部分长期债务: | | | | | | | |
信用协议:
|
| | | | | | |
定期贷款
|
| | | | 304,099 | | |
循环信贷安排
|
| | | | — | | |
发债成本
|
| | | | (5,319) | | |
总债务
|
| | | | 298,780 | | |
股东权益: | | | | | | | |
普通股,面值0.01美元,有表决权的普通股;6亿股,实际,152,979,479股已发行和流通股,实际,6亿股,经调整,已发行和已流通股,经调整
|
| | | | 1,529 | | |
新增实收资本
|
| | | | 884,528 | | |
累计亏损
|
| | | | (62,338) | | |
累计其他综合损失
|
| | | | (1,587) | | |
股东权益总额
|
| | | | 822,132 | | |
总市值
|
| | | $ | 1,269,400 | | |
|
名称
|
| |
年龄
|
| |
职位
|
| |||
威廉·F·费赫里
|
| | | | 50 | | | | 首席执行官兼董事 | |
M.Andrew Schemick
|
| | | | 47 | | | | 首席财务官 | |
罗伯特·阿斯伯里
|
| | | | 49 | | | | Simcyp总裁 | |
Justin Edge
|
| | | | 52 | | | | 监管和访问总裁 | |
莱夫·E·彼得森
|
| | | | 56 | | | | 软件总裁 | |
克雷格·R·雷纳
|
| | | | 47 | | | | 综合药物开发总裁 | |
理查德·M·特雷诺
|
| | | | 49 | | | | 高级副总裁兼总法律顾问 | |
崔洁恩
|
| | | | 46 | | | | 首席战略和营销官 | |
朱迪思·狄金森
|
| | | | 47 | | | | 首席人力资源官兼人力资源部高级副总裁 | |
Sherilyn S.McCoy
|
| | | | 62 | | | | 董事会主席 | |
詹姆斯·E·现金男三世
|
| | | | 67 | | | | 导演 | |
Eric C.Liu
|
| | | | 44 | | | | 导演 | |
斯蒂芬·M·麦克莱恩
|
| | | | 63 | | | | 导演 | |
Mason P.Slaine
|
| | | | 67 | | | | 导演 | |
马修·沃尔什
|
| | | | 54 | | | | 导演 | |
伊桑·瓦克斯曼
|
| | | | 32 | | | | 导演 | |
| | |
股票受益
之前拥有的 提供服务 |
| |
股票受益
上市后拥有 |
| ||||||||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | |
如果承销商的选择
额外购买 未行使股份 |
| |
如果承销商的选择
额外购买 股份全部行使 |
| ||||||||||||||||||||||||||||||
受益人姓名
|
| |
个共享
|
| |
百分比
|
| |
个共享
提供 特此 |
| |
个共享
|
| |
百分比
|
| |
个共享
提供 特此 |
| |
个共享
|
| |
百分比
|
| ||||||||||||||||||||||||
5%的股东: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
EQT投资者(1)
|
| | | | 74,898,012 | | | | | | 49.0% | | | | | | 7,542,740 | | | | | | 67,355,272 | | | | | | 44.0% | | | | | | 8,674,151 | | | | | | 66,223,861 | | | | | | 43.3% | | |
阿森纳投资者(2)
|
| | | | 10,503,127 | | | | | | 6.9% | | | | | | 1,057,736 | | | | | | 9,445,391 | | | | | | 6.2% | | | | | | 1,216,397 | | | | | | 9,286,730 | | | | | | 6.1% | | |
董事和指定高管: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||
威廉·F·费赫里(3)
|
| | | | 3,221,476 | | | | | | 2.1% | | | | | | — | | | | | | 3,221,476 | | | | | | 2.1% | | | | | | — | | | | | | 3,221,476 | | | | | | 2.1% | | |
Leif E.Pedersen(4)
|
| | | | 256,118 | | | | | | * | | | | | | — | | | | | | 256,118 | | | | | | * | | | | | | — | | | | | | 256,118 | | | | | | * | | |
M.Andrew Schemick(5)
|
| | | | 862,044 | | | | | | * | | | | | | — | | | | | | 862,044 | | | | | | * | | | | | | — | | | | | | 862,044 | | | | | | * | | |
Sherilyn S.McCoy
|
| | | | 614,084 | | | | | | * | | | | | | — | | | | | | 614,084 | | | | | | * | | | | | | — | | | | | | 614,084 | | | | | | * | | |
詹姆斯·E·现金男三世(6)
|
| | | | 476,723 | | | | | | * | | | | | | — | | | | | | 476,723 | | | | | | * | | | | | | — | | | | | | 476,723 | | | | | | * | | |
Eric C.Liu(7)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
斯蒂芬·M·麦克莱恩
|
| | | | 22,000 | | | | | | * | | | | | | — | | | | | | 22,000 | | | | | | * | | | | | | — | | | | | | 22,000 | | | | | | * | | |
Mason P.Slaine(8)
|
| | | | 2,732,555 | | | | | | 1.8% | | | | | | — | | | | | | 2,732,555 | | | | | | 1.8% | | | | | | — | | | | | | 2,732,555 | | | | | | 1.8% | | |
马修·沃尔什(9)
|
| | | | 172,901 | | | | | | * | | | | | | — | | | | | | 172,901 | | | | | | * | | | | | | — | | | | | | 172,901 | | | | | | * | | |
Ethan Waxman(7)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
所有董事和高管
集团(16人)(10) |
| | | | 10,428,491 | | | | | | 6.8% | | | | | | — | | | | | | 10,428,491 | | | | | | 6.8% | | | | | | — | | | | | | 10,428,491 | | | | | | 6.8% | | |
其他出售股东: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ||||||||||
Santo Holding(Deutschland)GmbH(11)
|
| | | | 5,251,564 | | | | | | 3.4% | | | | | | 528,868 | | | | | | 4,722,696 | | | | | | 3.1% | | | | | | 608,198 | | | | | | 4,643,366 | | | | | | 3.0% | | |
Samping Private Equity K/S(12)
|
| | | | 2,678,507 | | | | | | 1.8% | | | | | | 269,744 | | | | | | 2,408,763 | | | | | | 1.6% | | | | | | 310,205 | | | | | | 2,368,302 | | | | | | 1.5% | | |
Kirkbi投资A/S(13)
|
| | | | 2,678,297 | | | | | | 1.8% | | | | | | 269,723 | | | | | | 2,408,574 | | | | | | 1.6% | | | | | | 310,181 | | | | | | 2,368,116 | | | | | | 1.5% | | |
Monte Rosa Opportunities,SICAV-SIF(14)
|
| | | | 1,802,337 | | | | | | 1.2% | | | | | | 181,508 | | | | | | 1,620,829 | | | | | | 1.1% | | | | | | 208,734 | | | | | | 1,593,603 | | | | | | 1.0% | | |
霍华德·休斯医疗
学院(15) |
| | | | 1,482,107 | | | | | | 1.0% | | | | | | 149,258 | | | | | | 1,332,849 | | | | | | * | | | | | | 171,647 | | | | | | 1,310,460 | | | | | | * | | |
额外销售股东(1人)
|
| | | | 4,201 | | | | | | * | | | | | | 423 | | | | | | 3,778 | | | | | | * | | | | | | 487 | | | | | | 3,714 | | | | | | * | | |
名称
|
| |
股份数量
|
| |||
Jefferies LLC
|
| | | | 3,100,000 | | |
摩根士丹利有限责任公司
|
| | | | 3,100,000 | | |
美国银行证券公司
|
| | | | 2,000,000 | | |
瑞士信贷证券(美国)有限责任公司
|
| | | | 900,000 | | |
巴克莱资本公司(Barclays Capital Inc.)
|
| | | | 900,000 | | |
总计:
|
| | | | 10,000,000 | | |
|
| | |
每个
个
共享 |
| |
总计
|
| ||||||||||||
| | |
不锻炼
|
| |
已满
练习 |
| ||||||||||||
公开发行价
|
| | | $ | 25.000 | | | | | $ | 250,000,000 | | | | | $ | 287,500,000 | | |
承销折扣由出售股东支付
|
| | | $ | 0.875 | | | | | $ | 8,750,000 | | | | | $ | 10,062,500 | | |
向出售股东扣除费用前的收益
|
| | | $ | 24.125 | | | | | $ | 241,250,000 | | | | | $ | 277,437,500 | | |